Articles dans des revues avec comité de lecture (161)
  1. 85. Raicevic, G., Najar, M., Pieters, K., De Bruyn, C., Meuleman, N., Bron, D., Toungouz Nevessignsky, M., & Lagneaux, L. (2012). Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin. Tissue Engineering. Part A. Tissue Engineering, 18(13-14), 1410-1418. doi:10.1089/ten.TEA.2011.0434
  2. 86. Stamatopoulos, B., Meuleman, N., De Bruyn, C., Pieters, K., Mineur, P., Le Roy, C., Saint-Georges, S., Varin-Blank, N., Cymbalista, F., Bron, D., & Lagneaux, L. (2012). AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatments. Haematologica, 97(4), 608-615. doi:10.3324/haematol.2011.052779
  3. 87. Desmedt, C., Majjaj, S., Kheddoumi, N., Singhal, S. K., Haibe-Kains, B., El Ouriaghli, F., Chaboteaux, C., Michiels, S., Lallemand, F., Journé, F., Duvillier, H., Loi, S., Quackenbush, J., Dekoninck, S., Blanpain, C., Lagneaux, L., Houhou, N., Delorenzi, M., Larsimont, D., Piccart-Gebhart, M., & Sotiriou, C. (2012). Characterization and Clinical Evaluation of CD10+ Stroma Cells in the Breast Cancer Microenvironment. Clinical cancer research, 18(4), 1004-1014. doi:10.1158/1078-0432.CCR-11-0383
  4. 88. De Kock, J., Najar, M., Bolleyn, J., Al Battah, F., Raicevic, G., Govaere, O., Branson, S., Meganathan, K., Gaspar, J. A., Roskams, T., Sachinidis, A., Lagneaux, L., Vanhaecke, T., & Rogiers, V. (2012). Assessment of the intrinsic pluripotency of mesoderm-derived stem cells from different niches. Alternatives to animal experimentation, 531-539.
  5. 89. Id Boufker, H., Lagneaux, L., Fayyad Kazan, H., Badran, B., Najar, M., Wiedig, M., Ghanem, G. E., Laurent, G., Body, J.-J., & Journé, F. (2011). Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblasts. Bone, 49(6), 1219-1231. doi:10.1016/j.bone.2011.08.013
  6. 90. Raicevic, G., Najar, M., Stamatopoulos, B., De Bruyn, C., Meuleman, N., Bron, D., Toungouz Nevessignsky, M., & Lagneaux, L. (2011). The source of human mesenchymal stromal cells influences their TLR profile as well as their functional properties. Cellular immunology, 270(2), 207-216. doi:10.1016/j.cellimm.2011.05.010
  7. 91. De Bruyn, C., Najar, M., Raicevic, G., Meuleman, N., Pieters, K., Stamatopoulos, B., Delforge, A., Bron, D., & Lagneaux, L. (2011). A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from Wharton's jelly without enzymatic treatment. Stem cells and development, 20(3), 547-557. doi:10.1089/scd.2010.0260
  8. 92. De Bruyn, C., Najar, M., Raicevic, G., Meuleman, N., Pieters, K., Stamatopoulos, B., Delforge, A., Bron, D., & Lagneaux, L. (2011). A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from wharton's jelly without enzymatic treatment. Stem cells and development, 20(3), 547-557. doi:10.1089/scd.2010.0260
  9. 93. Najar, M., Raicevic, G., Boufker, H. I., Fayyad Kazan, H., De Bruyn, C., Meuleman, N., Bron, D., Toungouz Nevessignsky, M., & Lagneaux, L. (2010). Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor. Tissue Engineering. Part A. Tissue Engineering, 16(11), 3537-3546. doi:10.1089/ten.TEA.2010.0159
  10. 94. Najar, M., Raicevic, G., Id Boufker, H., Stamatopoulos, B., De Bruyn, C., Meuleman, N., Bron, D., Toungouz Nevessignsky, M., & Lagneaux, L. (2010). Modulated expression of adhesion molecules and galectin-1: role during mesenchymal stromal cell immunoregulatory functions. Experimental hematology, 38(10), 922-932. doi:10.1016/j.exphem.2010.05.007
  11. 95. Defoiche, J., Zhang, Y., Lagneaux, L., Willems, L., & Macallan, D. (2010). In vivo ribosomal RNA turnover is down-regulated in leukaemic cells in chronic lymphocytic leukaemia. British journal of haematology, 151(2), 192-195. doi:10.1111/j.1365-2141.2010.08334.x
  12. 96. Stamatopoulos, B., Meuleman, N., De Bruyn, C., Delforge, A., Bron, D., & Lagneaux, L. (2010). The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) induces apoptosis, downregulates the CXCR4 chemokine receptor and impairs migration of chronic lymphocytic leukemia cells. Haematologica, 95(7), 1136-1143. doi:10.3324/haematol.2009.013847
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Suivant >>